TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
KOD

Kodiak Sciences Inc

Healthcare · Biotechnology

32.70$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Kodiak Sciences Inc (KOD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KOD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.0 0.0 0.0 0.0 0.0 27 0.0 0.0 0.0 0.0 0.0 0.0 0.0
7.0 6.7 6.6 6.7 6.7 6.7 6.7 6.5 6.5 -20 6.3
-7.0 -6.7 -6.6 -6.7 -6.7 -6.7 -6.7 -6.5 -6.5 20 -6.3
36 47 30 33 32 32 44 43 50 45 49 56 201
18 17 16 15 15 14 14 13 12 12 11 11 46
48 57 39 41 40 39 59 56 62 57 60 67 246
-55 -63 -46 -48 -47 -46 -59 -56 -62 -57 -60 -67 -246
0.0 0.0 0.0 0.0 0.0 0.0
-50 -60 -43 -45 -44 -44 -57 -54 -61 -57 -58 -66 -242
-7.0 6.6 6.6 -44 -6.6
-50 -60 -43 -45 -44 -44 -57 -54 -61 -57 -58 -66 -242
-43 -53 -36 -38 -37 -37 -51 -48 -55 -47 -52 -67 -220

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?